Friedreich Ataxia

Overview


Plain-Language Overview

Friedreich Ataxia is a rare inherited disorder that primarily affects the nervous system and causes problems with movement and coordination. It usually begins in childhood or adolescence and leads to difficulty walking, loss of balance, and muscle weakness. The condition also affects the heart, often causing cardiomyopathy, and can lead to diabetes. It results from damage to the spinal cord and peripheral nerves, which are important for sending signals between the brain and muscles. Over time, symptoms worsen, impacting daily activities and overall health. The disease is caused by a genetic mutation that affects a protein important for energy production in cells.

Clinical Definition

Friedreich Ataxia is an autosomal recessive neurodegenerative disorder caused by a GAA trinucleotide repeat expansion in the FXN gene, leading to decreased production of frataxin, a mitochondrial protein essential for iron-sulfur cluster biogenesis. This deficiency results in mitochondrial dysfunction, oxidative stress, and progressive degeneration of the dorsal root ganglia, spinocerebellar tracts, and corticospinal tracts. Clinically, it presents with progressive gait and limb ataxia, loss of deep tendon reflexes, dysarthria, and cardiomyopathy. The disease typically manifests before age 25 and is the most common inherited ataxia. Additional features include scoliosis, pes cavus, and diabetes mellitus. The neurological decline is due to combined sensory and motor pathway involvement, leading to impaired proprioception and muscle weakness.

Inciting Event

Locked content.

Latency Period

Locked content.

Diagnostic Delay

Locked content.

Clinical Presentation


Signs & Symptoms

Locked content.

History of Present Illness

Locked content.

Past Medical History

Locked content.

Family History

Locked content.

Physical Exam Findings

Locked content.

Diagnostic Workup


Diagnostic Criteria

Locked content.

Pathophysiology


Key Mechanisms

Locked content.

Organs

Locked content.

Tissues

Locked content.

Cells

Locked content.

Chemical Mediators

Locked content.

Treatments


Pharmacological Treatments

Locked content.

Non-pharmacological Treatments

Locked content.

Prevention


Pharmacological Prevention

Locked content.

Non-pharmacological Prevention

Locked content.

Outcome & Complications


Complications

Locked content.

Short-term Sequelae

Locked content.

Long-term Sequelae

Locked content.

Differential Diagnoses


Differentials

Locked content.

Medical Disclaimer: The content on this site is for educational purposes only and is not a substitute for professional medical advice, diagnosis, or treatment. If you think you may be experiencing a medical emergency, call 911 or your local emergency number immediately. Always consult a licensed healthcare professional with questions about a medical condition.

Artificial Intelligence Use: Portions of this site's content were generated or assisted by AI. All material has been reviewed by Erik Romano, MD, however, errors or omissions may still occur.

USMLE® is a registered trademark of the Federation of State Medical Boards (FSMB) and the National Board of Medical Examiners (NBME). Doctogenic and Roscoe & Romano are not affiliated with, sponsored by, or endorsed by the USMLE, FSMB, or NBME. Neither FSMB nor NBME has reviewed or approved this content. “USMLE Step 1” and “USMLE Step 2 CK” are used only to identify the relevant examinations.